BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35088997)

  • 1. Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell Tumor.
    Barragán-Carrillo R; Mateos-Corella S; Ortiz-Hidalgo C; Izquierdo-Echavarri E; Castillejos-Molina R; Angel M; Barragan-Arteaga I; Flaig T; Bourlon MT
    Oncology (Williston Park); 2021 Dec; 35(12):816-819. PubMed ID: 35088997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of spermatic cord teratoma in low-stage testicular cancer managed by surveillance.
    Subramanian VS; Gilligan T; Klein EA
    Nat Clin Pract Urol; 2008 Apr; 5(4):220-3. PubMed ID: 18268549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
    Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
    Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late testicular relapse two decades after primary extragonadal germ cell tumor with uncommon metastases: a case report.
    Tobiume M; Aoki S; Nishikawa G; Muramatsu H; Ono K; Morinaga S; Hara K; Ando N; Ono K; Nishibata C; Hidano A; Nakagawa M; Takahashi I; Matsubara K; Yamada Y
    J Med Case Rep; 2021 Feb; 15(1):59. PubMed ID: 33541424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 8. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD; Foster RS; Bihrle R; Donohue JP
    Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)].
    Nicolai N; Necchi A; Piva L; Stagni S; Catanzaro MA; Biasoni D; Milani A; Torelli T; Salvioni R
    Urologia; 2010; 77(2):84-7. PubMed ID: 20890864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D
    Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A CASE OF ADVANCED NON-SEMINOMATOUS TESTICULAR GERM CELL TUMOR ACCOMPANIED PANIC DISORDER].
    Okumura A; Morii A; Kiriyama M; Takamatsu H; Shimizu M; Yasui S; Takagawa K
    Nihon Hinyokika Gakkai Zasshi; 2016; 107(1):48-53. PubMed ID: 28132992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Metachronous Testicular Tumor Developing Twenty Years after Treatment of Retroperitoneal Extragonadal Germ Cell Tumor].
    Tobiume M; Yamada Y; Aoki S; Hara K; Muramatsu H; Nishikawa G; Ono K; Takayanagi Y; Nakamura K
    Hinyokika Kiyo; 2020 Jun; 66(6):171-176. PubMed ID: 32605355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of far-advanced retroperitoneal extra-gonadal germ cell tumor responding to intensive treatment including multi-drug chemotherapy with peripheral blood stem cell transplantation and residual tumor removal].
    Yamashita T; Morozumi M; Takagi D; Yoshinaga A; Ishii N; Matsuda T; Terao T; Yamada T
    Nihon Hinyokika Gakkai Zasshi; 2010 Mar; 101(3):565-9. PubMed ID: 20387517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified retroperitoneal lymph node dissection for post-chemotherapy residual tumour: a long-term update.
    Cho JS; Kaimakliotis HZ; Cary C; Masterson TA; Beck S; Foster R
    BJU Int; 2017 Jul; 120(1):104-108. PubMed ID: 28296054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
    Gilligan T
    J Clin Oncol; 2016 Feb; 34(4):303-6. PubMed ID: 26668343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneously detected bilateral testicular cancer of different histopathological origin--a challenging situation for the urologist.
    Hammerich KH; Schroeck FR; West D; Moul JW
    Oncology (Williston Park); 2010 Jul; 24(8):757-60. PubMed ID: 20718257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision analysis defining optimal management of clinical stage 1 high-risk nonseminomatous germ cell testicular cancer with lymphovascular invasion.
    Avulova S; Allen C; Morgans A; Moses KA
    Urol Oncol; 2018 Jul; 36(7):342.e1-342.e6. PubMed ID: 29754945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
    Pagliaro LC
    J Clin Oncol; 2017 Apr; 35(10):1036-1040. PubMed ID: 27992270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Significance of a Small Component of Choriocarcinoma in Testicular Mixed Germ Cell Tumor (MGCT).
    Hassan O; Epstein JI
    Am J Surg Pathol; 2018 Aug; 42(8):1113-1120. PubMed ID: 29794869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.